Analysis of Critical COVID-19 Cases Among Children in Korea

Hyunju Lee1,2, Sujin Choi1,2, Ji Young Park3

  • 1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.

Insights

Critical COVID-19 in children is rare but can be severe. This study highlights that obesity is a significant risk factor in pediatric critical COVID-19 cases, with no reported fatalities.

Area of Science:

  • Pediatric Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) typically presents as asymptomatic or mild in children.
  • Severe COVID-19 cases can occur in pediatric populations, necessitating further investigation into risk factors and clinical characteristics.

Purpose of the Study:

  • To report the clinical characteristics of children classified as critical COVID-19 in Korea.
  • To provide insights into risk factors and management strategies for severe COVID-19 in pediatric patients.

Main Methods:

  • Retrospective case series of pediatric patients (< 18 years) with critical COVID-19.
  • Data collected from the Korea Disease Control and Prevention Agency surveillance system and medical records.
  • Critical COVID-19 defined by need for mechanical ventilation, ECMO, or CRRT.

Main Results:

  • Eight cases (0.02%) of critical COVID-19 identified among 39,146 pediatric COVID-19 diagnoses.
  • Median age was 13 years; 7 out of 8 critical cases were obese.
  • Common symptoms included fever and dyspnea; pneumonia was radiographically evident. All patients received steroids, and some required mechanical ventilation or ECMO. No fatalities occurred.

Conclusions:

  • Monitoring and assessing the clinical burden of COVID-19 in children are crucial.
  • Findings underscore the importance of considering obesity as a risk factor for severe COVID-19 in children.
  • Informing policy development for pediatric pandemic management is essential.
Abstract

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
765
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
249
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12